知镜 Cognispect · 医学文献与研究工作台

Vulnerability and Immunogenic Cell Death under Microwave Ablation for Synergistic Treatment of Hepatocellular Carcinoma.

Chen Z, Xu H, Peng Y, Zhu M, Huang L, Fang F, Chen K.
Biomaterials research · 2026-10-08 · PMID 42851518

文献摘要

Microwave ablation (MWA) holds great promise for hepatocellular carcinoma but is often limited by incomplete tumor eradication and recurrence. Here, we report a tumor-killing nanoimmunoreactor driven by endogenous immune cues that synergizes with MWA to eliminate residual tumors and activate systemic antitumor immunity. The 17-AAG-MnO 2 PEG nanoimmunoreactor consists of a self-responsive PEGylated MnO 2 platform loaded with the HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin (17-AAG), which is designed to respond to the oxidative tumor microenvironment. 17-AAG disrupts tumor cell thermotolerance, enhancing sensitivity to microwave-induced thermal stress, thereby improving ablation efficacy and inducing immunogenic cell death. PEGylation facilitates tumor-targeted accumulation, while the degradable MnO 2 responds to hydrogen peroxide (H 2 O 2 ) and tumor debris generated after MWA, enabling sustained local drug release. The combination treatment promotes dendritic cell maturation and T cell infiltration, effectively suppresses residual tumor regrowth, reduces the risk of metastasis, and establishes durable immune memory. By leveraging post-ablation tumor debris and microenvironmental cues, this strategy couples local tumor ablation with systemic antitumor immunity, providing a mechanistically distinct paradigm for durable cancer therapy.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。